These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro. Schoenfeld N; Epstein O; Atsmon A Biochim Biophys Acta; 1976 Aug; 444(1):286-93. PubMed ID: 8132 [TBL] [Abstract][Full Text] [Related]
29. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity. Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768 [TBL] [Abstract][Full Text] [Related]
30. Induction of delta-aminolevulinic acid synthetase in isolated rat liver cell suspensions. Adenosine 3':5'-monophosphate dependence of induction by drugs. Edwards AM; Elliott WH J Biol Chem; 1974 Feb; 249(3):851-5. PubMed ID: 4359771 [No Abstract] [Full Text] [Related]
32. Stimulation of hydroxymethylglutaryl-CoA reductase activity after a single dose of the porphyrogenic chemical, allylisopropylacetamide. Sanghvi A; Parikh B Biochim Biophys Acta; 1978 Oct; 531(1):79-85. PubMed ID: 708750 [TBL] [Abstract][Full Text] [Related]
33. The porphyrias [corrected]: characteristics and laboratory tests. Ellefson RD; Ford RE Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S119-25. PubMed ID: 8921566 [TBL] [Abstract][Full Text] [Related]